Scyllo-Inositol

CAS No. 488-59-5

Scyllo-Inositol( Scyllitol )

Catalog No. M21272 CAS No. 488-59-5

Scyllo-Inositol is one of the inositol stereoisomers rare in the nature and expected as a promising disease-modifying therapeutic agent for Alzheimer's disease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 32 In Stock
10MG 53 In Stock
25MG 85 In Stock
50MG 129 In Stock
100MG 206 In Stock
200MG 305 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Scyllo-Inositol
  • Note
    Research use only, not for human use.
  • Brief Description
    Scyllo-Inositol is one of the inositol stereoisomers rare in the nature and expected as a promising disease-modifying therapeutic agent for Alzheimer's disease.
  • Description
    Scyllo-Inositol is one of the inositol stereoisomers rare in the nature and expected as a promising disease-modifying therapeutic agent for Alzheimer's disease.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Scyllitol
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Beta Amyloid
  • Recptor
    amyloid-β
  • Research Area
    Neurological Disease
  • Indication
    Alzheimer's Disease

Chemical Information

  • CAS Number
    488-59-5
  • Formula Weight
    180.16
  • Molecular Formula
    C6H12O6
  • Purity
    >98% (HPLC)
  • Solubility
    H2O:5 mg/mL (27.75 mM; Need ultrasonic)
  • SMILES
    O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ibrahim T Mclaurin J A . α-Synuclein aggregation seeding and inhibition by scyllo-inositol[J]. Biochemical & Biophysical Research Communications 2015:S0006291X15310482.
molnova catalog
related products
  • Solanezumab

    Solanezumab (LY 2062430) is a monoclonal antibody that binds preferentially to soluble amyloid and promotes its clearance from the brain.Solanezumab is used in the study of Alzheimer's disease.

  • Amyloid beta-peptide...

    Amyloid beta-peptide(25-35) is the fragment Aβ(25-35) of the Alzheimer's amyloid β-peptide. Which has shown neurotoxic activities in cultured cells. The amino acid sequence of Aβ(25-35) peptide is NH2-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-COOH, where the first Gly represents the amino acid 25 and the last Met represents the amino acid 35 and it is also investigated in gel state for the first time.

  • Methyl tridecanoate

    Methyl tridecanoate inhibits β-amyloid aggregation moderately and inhibits acetylcholinesterase (AChE) weekly.